OXiGENE, Inc.

Organization

South San Francisco, CA, US

Ticker Symbols

NASDAQ:MATN

PHARMACEUTICAL PREPARATIONS
Business Address
701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
Mailing Address
701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
State Location
CA
State of Incorporation
DE

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Compositions and methods for inhibition of cathepsins
- Patent number 9,873,668
- Issue date Jan 23, 2018
- Mateon Therapeutics, Inc.
- David J. Chaplin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for inhibition of cathepsins
- Patent number 9,458,103
- Issue date Oct 4, 2016
- Mateon Therapeutics, Inc.
- David J. Chaplin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Functionalized stilbene derivatives as improved vascular targeting...
- Patent number RE45907
- Issue date Mar 1, 2016
- OXiGENE, Inc.
- David J. Chaplin
- 001 -
Information Patent Grant
Functionalized stilbene derivatives as improved vascular targeting...
- Patent number RE45720
- Issue date Oct 6, 2015
- OXiGENE, Inc.
- David J. Chaplin
- 001 -
Information Patent Grant
Method for treating hematopoietic neoplasms
- Patent number 9,040,500
- Issue date May 26, 2015
- OXiGENE, Inc.
- David Chaplin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for inhibition of cathepsins
- Patent number 8,877,967
- Issue date Nov 4, 2014
- OXiGENE, Inc.
- David J. Chaplin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods with enhanced therapeutic activity
- Patent number 8,198,302
- Issue date Jun 12, 2012
- OXiGENE, Inc.
- David J. Chaplin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chromene-containing compounds with anti-tubulin and vascular target...
- Patent number 7,456,214
- Issue date Nov 25, 2008
- Baylor University
- Kevin G. Pinney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Functionalized stilbene derivatives as improved vascular targeting...
- Patent number 7,384,925
- Issue date Jun 10, 2008
- OXiGENE, Inc.
- David J. Chaplin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Control of acute hypertension and cardiotoxicity in patients treate...
- Patent number 7,358,236
- Issue date Apr 15, 2008
- OXiGENE, Inc.
- David Chaplin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tubulin binding ligands and corresponding prodrug constructs
- Patent number 7,091,240
- Issue date Aug 15, 2006
- Oxigene, Inc.
- Kevin G. Pinney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for modulating tumor growth and metastasis
- Patent number 7,037,906
- Issue date May 2, 2006
- Oxigene, Inc.
- Francis Y. Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tubulin binding agents and corresponding prodrug constructs
- Patent number 7,001,926
- Issue date Feb 21, 2006
- OXiGENE, Inc.
- Kevin G. Pinney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for use in targeting vascular destruction
- Patent number 6,956,054
- Issue date Oct 18, 2005
- Baylor University
- Ronald W. Pero
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Functionalized stilbene derivatives as improved vascular targeting...
- Patent number 6,919,324
- Issue date Jul 19, 2005
- OXiGENE, Inc.
- David J. Chaplin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of combretastatin A4 and its prodrugs as an immune enhancing th...
- Patent number 6,773,702
- Issue date Aug 10, 2004
- OXiGENE, Inc.
- Ronald W. Pero
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Efficient method of synthesizing combretastatin A-4 prodrugs
- Patent number 6,743,937
- Issue date Jun 1, 2004
- Oxigene, Inc.
- Faye Seyedi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of aryl N-substituted carboxamides directly and as radio-and ch...
- Patent number 6,713,517
- Issue date Mar 30, 2004
- Oxigene, Inc.
- Ronald W. Pero
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for use in targeting vascular destruction
- Patent number 6,538,038
- Issue date Mar 25, 2003
- Oxigene, Inc.
- Ronald W. Pero
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Uses of nicotinamide adenine dinucleotide and its derivatives for t...
- Patent number 6,339,073
- Issue date Jan 15, 2002
- Oxigene, Inc.
- Ronald W. Pero
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-acetyl 3-chloroprocainamide, acid addition salts thereof, and met...
- Patent number 6,100,299
- Issue date Aug 8, 2000
- OXiGENE, Inc.
- Ronald W. Pero
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and use of benzamides and nicotinamides as anti-inflam...
- Patent number 6,028,111
- Issue date Feb 22, 2000
- OXiGENE, Inc.
- Ronald W. Pero
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Carotenoid-nicotinamide-zinc compositions and methods of treatment...
- Patent number 6,020,351
- Issue date Feb 1, 2000
- OXiGENE, Inc.
- Ronald W. Pero
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of administering phenothiazines and/or acid addition salts...
- Patent number 5,561,129
- Issue date Oct 1, 1996
- OXiGENE, Inc.
- Ronald W. Pero
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of administering and pharmaceutical formulations containing...
- Patent number 5,561,161
- Issue date Oct 1, 1996
- OXiGENE, Inc.
- Ronald W. Pero
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
USE OF VDAS TO ENHANCE IMMUNOMODULATING THERAPIES AGAINST TUMORS
- Publication number 20190008956
- Publication date Jan 10, 2019
- MATEON THERAPEUTICS, INC.
- David J. CHAPLIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR INHIBITION OF CATHEPSINS
- Publication number 20190010173
- Publication date Jan 10, 2019
- MATEON THERAPEUTICS, INC.
- Kevin G. Pinney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and Methods for Inhibition of Cathepsins
- Publication number 20150031915
- Publication date Jan 29, 2015
- OXIGENE, INC.
- David J. Chaplin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Ophthalmic Formulations
- Publication number 20130136752
- Publication date May 30, 2013
- OXIGENE, INC.
- Suman Sharma
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR TREATING HEMATOPOIETIC NEOPLASMS
- Publication number 20120270831
- Publication date Oct 25, 2012
- OXIGENE, INC.
- David Chaplin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combretastatins for Prevention of Posterior Capsule Opacification
- Publication number 20120220554
- Publication date Aug 30, 2012
- OXIGENE, INC.
- Roy Quinlan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods for Enhancing the Efficacy of Vascular Disrupting Agents
- Publication number 20110110940
- Publication date May 12, 2011
- OXIGENE, INC.
- Robert Kerbel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR TREATING HEMATOPOIETIC NEOPLASMS
- Publication number 20090192098
- Publication date Jul 30, 2009
- OXIGENE, INC.
- David Chaplin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and Methods With Enhanced Therapeutic Activity
- Publication number 20090137687
- Publication date May 28, 2009
- OXiGENE, Inc.
- David Chaplin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
87682252 - MATEON THERAPEUTICS
- Serial number 87682252
- Registration number 5502205
- Filing date Nov 13, 2017
- Mateon Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
86938900 - MATEON
- Serial number 86938900
- Filing date Mar 14, 2016
- MATEON THERAPEUTICS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
77982121 - ZYBRESTAT
- Serial number 77982121
- Registration number 4099600
- Filing date Dec 13, 2006
- OXiGENE, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
77063392 - ZYBRESTAT
- Serial number 77063392
- Filing date Dec 13, 2006
- OXiGENE, Inc.
- 44 - Medical services
Information Trademark
76455449 - OXIGENE
- Serial number 76455449
- Registration number 2741640
- Filing date Oct 3, 2002
- OXIGENE, INC.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
76351863 - OXIGENE
- Serial number 76351863
- Registration number 2697427
- Filing date Dec 21, 2001
- OXIGENE, INC.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
76306207 - OXIGENE THE VASCULAR TARGETING COMPANY
- Serial number 76306207
- Registration number 2893720
- Filing date Aug 28, 2001
- OXIGENE, INC.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
74565103 - NEU-SENSAMIDE
- Serial number 74565103
- Filing date Aug 24, 1994
- OXiGENE, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
74455796 - SENSAMIDE
- Serial number 74455796
- Filing date Nov 9, 1993
- OXiGENE, INC.
- 5 - Pharmaceutical and veterinary preparations

OXiGENE, Inc.

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Compositions and methods for inhibition of cathepsins

Compositions and methods for inhibition of cathepsins

Functionalized stilbene derivatives as improved vascular targeting...

Functionalized stilbene derivatives as improved vascular targeting...

Method for treating hematopoietic neoplasms

Compositions and methods for inhibition of cathepsins

Compositions and methods with enhanced therapeutic activity

Chromene-containing compounds with anti-tubulin and vascular target...

Functionalized stilbene derivatives as improved vascular targeting...

Control of acute hypertension and cardiotoxicity in patients treate...

Tubulin binding ligands and corresponding prodrug constructs

Methods for modulating tumor growth and metastasis

Tubulin binding agents and corresponding prodrug constructs

Compositions and methods for use in targeting vascular destruction

Functionalized stilbene derivatives as improved vascular targeting...

Use of combretastatin A4 and its prodrugs as an immune enhancing th...

Efficient method of synthesizing combretastatin A-4 prodrugs

Use of aryl N-substituted carboxamides directly and as radio-and ch...

Compositions and methods for use in targeting vascular destruction

Uses of nicotinamide adenine dinucleotide and its derivatives for t...

N-acetyl 3-chloroprocainamide, acid addition salts thereof, and met...

Compositions and use of benzamides and nicotinamides as anti-inflam...

Carotenoid-nicotinamide-zinc compositions and methods of treatment...

Methods of administering phenothiazines and/or acid addition salts...

Methods of administering and pharmaceutical formulations containing...

Patents Applicationslast 30 patents

USE OF VDAS TO ENHANCE IMMUNOMODULATING THERAPIES AGAINST TUMORS

COMPOSITIONS AND METHODS FOR INHIBITION OF CATHEPSINS

Compositions and Methods for Inhibition of Cathepsins

Ophthalmic Formulations

METHOD FOR TREATING HEMATOPOIETIC NEOPLASMS

Combretastatins for Prevention of Posterior Capsule Opacification

Methods for Enhancing the Efficacy of Vascular Disrupting Agents

METHOD FOR TREATING HEMATOPOIETIC NEOPLASMS

Compositions and Methods With Enhanced Therapeutic Activity

Trademarklast 30 trademarks

87682252 - MATEON THERAPEUTICS

86938900 - MATEON

77982121 - ZYBRESTAT

77063392 - ZYBRESTAT

76455449 - OXIGENE

76351863 - OXIGENE

76306207 - OXIGENE THE VASCULAR TARGETING COMPANY

74565103 - NEU-SENSAMIDE

74455796 - SENSAMIDE